|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03737 ZHONGZHIPHARM
Nominal 
0.670 -0.020 (-2.899%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 880,480 | -19.105% | 1,088,426 | 1,094,328 | 846,397 | 886,716 |
| Cost of Sales | (397,962) | -13.745% | (461,380) | (419,365) | (341,214) | (340,898) |
| Gross Profit | 482,518 | -23.049% | 627,046 | 674,963 | 505,183 | 545,818 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (2,772) | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 600 | -99.429% | 105,019 | 167,819 | 95,414 | 80,156 | |
| Taxation | 8,217 | -- | (20,767) | (31,667) | (17,875) | (13,612) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (34) | -95.813% | (812) | (1,252) | (491) | 44 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 8,783 | -89.474% | 83,440 | 134,900 | 77,048 | 66,588 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 760 | -56.196% | 1,735 | 45 | 1,076 | 1,316 |
| Depreciation & Amortisation | 47,406 | -7.144% | 51,053 | 50,015 | 45,934 | 40,984 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 1.000 | -89.899% | 9.900 | 15.900 | 9.100 | 8.100 |
| DPS (cts) | 0.000 | -- | 0.000 | 5.502 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | 34.604% | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 1.257 | -- | 1.282 | 1.237 | 1.129 | 1.051 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 8,783 |
| %Change | -89.474% |
| EPS / (LPS) | RMB 0.010 |
| NBV Per Share (¥) | RMB 1.257 |